Drugs / iRGD
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01741597 | Jul 2014 → Jul 2016 | breast carcinoma, liver cancer, pancreatic acinar cell carcinoma, pancreatic ductal adenocarcinoma +1 | City of Hope Medical Center | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | iRGD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01741597 ↗ |
| Modality | Peptide | “tumor-homing peptide iRGD” NCT01741597 ↗ |